NEW YORK, May 1 – Ciphergen Biosystems reported Tuesday an 80 percent increase in first-quarter revenues to $2.7 million from $1.5 million in the year-ago quarter.

The company attributed the increase to greater sales of its ProteinChip systems and arrays in addition to service revenue from their Biomarker Discovery Centers. The growth represents “continued progress in our mission of enabling benchtop biologists to perform proteomics research," William Rich, CEO of Ciphergen, said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.